TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
MANHATTAN, N.Y., Sept. 12, 2017 -- Epica International, Inc., a leading robotic CT company based in San Clemente, California, recently announced the closing of a financing round with the investment group, Partners for Growth. PFG structured the $5 million term-debt facility in a key capital raise, providing growth capital to support Epica’s expansion into new markets across both imaging and robotics.
The NYC management consultancy, Facilitated Growth, acted as the key advisor on this deal, assisting in the rigorous diligence process for Epica’s five growing subsidiaries; a non-invasive CT medical imaging company, a robotics company, an advanced R&D technology center, a medical products distribution company, and a technical and scientific distribution group.
The funds are earmarked for use on growing operations, increasing the sales force, and preparing for entry into the human market. “This infusion of capital will assist us in furthering our goals to integrate CT imagery with precision robotics and ultimately deliver the future of medical diagnosis and therapy,” said Epica CEO, Frank D’Amelio.
Contact Info: Joe Soto, Facilitated Growth, [email protected], 212-697-1316
